Optimizing proton pump inhibitors in Helicobacter pylori treatment:Old and new tricks to improve effectiveness

查看全文 作　　者：Enzo [1]Ierardi;Giuseppe [1]Losurdo;Rosa Federica La [1]Fortezza;Mariabeatrice [1]Principi;Michele [1]Barone;Alfredo Di [1]Leo

机构地区：[1]Section of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari

出　　处：《World Journal of Gastroenterology》索引2019年第25卷第34期,共8页

摘　　要：The survival and replication cycle of Helicobacter pylori(H.pylori)is strictly dependant on intragastric pH,since H.pylori enters replicative phase at an almost neutral pH(6-7),while at acid pH(3-6)it turns into its coccoid form,which is resistant to antibiotics.On these bases,it is crucial to increase intragastric pH by proton pump inhibitors(PPIs)when an antibiotic-based eradicating therapy needs to be administered.Therefore,several tricks need to be used to optimize eradication rate of different regimens.The administration of the highest dose as possible of PPI,by doubling or increasing the number of pills/day,has shown to be able to improve therapeutic outcome and has often proposed in rescue therapies,even if specific trials have not been performed.A pre-treatment with PPI before starting antibiotics does not seem to be effective,therefore it is discouraged.However,the choice of PPI molecule could have a certain weight,since second-generation substances(esomeprazole,rabeprazole)are likely more effective than those of first generation(omeprazole,lansoprazole).A possible explanation is due to their metabolism,which has been proven to be less dependent on cytochrome P450(CYP)2C19 genetic variables.Finally,vonoprazan,a competitive inhibitor of H+/K+-ATPase present on luminal membrane of gastric parietal cells has shown the highest efficacy,due to both its highest acid inhibition power and rapid pharmacologic effect.However current data come only from Eastern Asia,therefore its strong power needs to be confirmed outside this geographic area in Western countries as well as related to the local different antibiotic resistance rates. 关键词：HELICOBACTER PYLORI Proton pump inhibitors ERADICATION CYTOCHROME P450 Optimization

相关文献

参考文献（64）
引证文献（23）
耦合文献（28）

参考文献(64)

引证文献(23)

耦合文献(28)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Optimizing proton pump inhibitors in Helicobacter pylori treatment:Old and new tricks to improve effectiveness

参考文献(64)

引证文献(23)

耦合文献(28)

用户提示